Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-2027
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia ; day:8 ; month:9 ; year:2018 ; pages:1-11
PharmacoEconomics ; (8.9.2018), 1-11
- Creator
-
Bounthavong, Mark
- Contributor
-
Butler, Javed
Dolan, Chantal M.
Dunn, Jeffrey D.
Fisher, Kathryn A.
Oestreicher, Nina
Pitt, Bertram
Hauptman, Paul J.
Veenstra, David L.
SpringerLink (Online service)
- DOI
-
10.1007/s40273-018-0709-3
- URN
-
urn:nbn:de:101:1-2018102607385361323118
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bounthavong, Mark
- Butler, Javed
- Dolan, Chantal M.
- Dunn, Jeffrey D.
- Fisher, Kathryn A.
- Oestreicher, Nina
- Pitt, Bertram
- Hauptman, Paul J.
- Veenstra, David L.
- SpringerLink (Online service)
Other Objects (12)
Clinical effectiveness and cost-effectiveness of ambulatory heart failure nurse-led services: an integrated review
Strategies for cost-effectiveness analysis of rehabilitation for older patients with acute heart failure
Health effectiveness and cost-effectiveness of telehealthcare for heart failure: study protocol for a randomized controlled trial
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
A European multinational cost-effectiveness analysis of empagliflozin in heart failure with reduced ejection fraction
Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes
Evaluating Cost-Effectiveness Models for Pharmacologic Interventions in Adults with Heart Failure: A Systematic Literature Review
Cost-effectiveness of the MitraClip device in German heart failure patients with secondary mitral regurgitation
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Clinical effectiveness and cost-effectiveness of ambulatory heart failure nurse-led services: an integrated review
Strategies for cost-effectiveness analysis of rehabilitation for older patients with acute heart failure
Health effectiveness and cost-effectiveness of telehealthcare for heart failure: study protocol for a randomized controlled trial
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
A European multinational cost-effectiveness analysis of empagliflozin in heart failure with reduced ejection fraction
Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes
Evaluating Cost-Effectiveness Models for Pharmacologic Interventions in Adults with Heart Failure: A Systematic Literature Review
Cost-effectiveness of the MitraClip device in German heart failure patients with secondary mitral regurgitation
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Clinical effectiveness and cost-effectiveness of ambulatory heart failure nurse-led services: an integrated review
Strategies for cost-effectiveness analysis of rehabilitation for older patients with acute heart failure
Health effectiveness and cost-effectiveness of telehealthcare for heart failure: study protocol for a randomized controlled trial
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
A European multinational cost-effectiveness analysis of empagliflozin in heart failure with reduced ejection fraction
Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes
Evaluating Cost-Effectiveness Models for Pharmacologic Interventions in Adults with Heart Failure: A Systematic Literature Review
Cost-effectiveness of the MitraClip device in German heart failure patients with secondary mitral regurgitation
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study